“EMR – one year on”
On April 30th the RCH Electronic Medical Record will have been in use for 12 months. It has been one of the biggest practice changes in the hospital’s history.
Author Archives: pamela
‘Factitious Disorders by Proxy’ (when parents inappropriately drive medical investigation and treatment)
“Factitious Disorders by Proxy” occur when caregivers (usually parents) exaggerate and/or fabricate symptoms and signs of illness in a child. This can sometimes be driven by an underlying personality disorder in the caregiver, or because of excessive anxiety that a serious illness is being missed by health care professionals.
Renal Genetics From bedside to bench and back again
Although individually rare, there are many inherited and tubular disorders of the kidney affecting children and adults. This talk will offer a bedside-to-bench-and-back overview of some of the clinical issues facing patients with rare kidney disorders, together with our genetic and cell biological discoveries concerning the C-terminal tails of individual proteins, and why they are so important in ensuring normal renal tubular function.
Leaving the cocoon – Helping young people with intellectual disabilities, autism and associated mental health problems move into the adult world
Synopsis In Australia, over 40% of children with intellectual disability (ID) and/or autism spectrum disorder (ASD) have mental health problems requiring long term psychiatric care. However access to such treatment is inadequate, particularly in adult services. This impacts upon timely transition from the RCH and has the potential to create longer-term negative impacts on the health … Continued
Cognitive computing and disruptive innovation
Advances in cognitive computing are redefining human work. After IBM’s Supercomputer Watson crushed human champions at the quiz show Jeopardy, IBM turned to making Watson the world’s best oncologist. Will the next generation Watson replace clinicians altogether, or will we be protected by our unique combination of cognitive and physical skills?
Improving outcomes in infantile epilepsies
The incidence of epilepsy is highest in infancy. Many infant epilepsies, such as infantile spasms, are very severe, with treatment-resistant seizures and major developmental impairments.
This Grand Round will cover advances in understanding of the causes of infant epilepsies, and how these advances have informed changes in investigation of aetiology and guided use of existing and novel treatments, to improve outcomes in these devastating conditions.
The Victorian Commission for Children and Young People
Ten months into her term as Commissioner of Children and Young People, Liana Buchanan will reflect on the issues affecting children and young people, and discuss some of the Commission’s current projects and priorities.
Domestic and Family Violence: Early intervention in paediatric settings is urgently needed, and the role of health-justice partnerships
This Grand Round explores the role of health professionals in family violence identification and response.
Professor Kelsey Hegarty will discuss how the consequences of family violence are commonly seen in health care settings, and the high intersection of domestic violence and child abuse means that paediatric and women’s health settings have a major role to play in early intervention. Ms Linda Gyorki will talk about how legal problems can have a detrimental impact on health and wellbeing.
Improving the oral health of children: Approaches to inequalities, prevention and the role of the paediatrician
Dental decay is one of the most preventable and consequential conditions of childhood. The health of children’s teeth is an important public health and clinical issue for dental and non-dental health practitioners alike, and has far reaching effects throughout life.
The cargo cult of diabetes care: An illustrative dilemma of non-transformative, resource-intensive therapies
Current medical practice is appropriately centred around notions of patient-centred care and personalised medicine. These laudable practices are occurring against a background increasing patient empowerment and disruptive patterns of knowledge transfer. Health care consumers are now interconnected and highly aware of biotechnological advances. Both health care providers and consumers want the latest and “best” in therapies, however all too frequently these therapies are both expensive and non-transformative.